Genomic landscape of colitis-associated cancer indicates the impact of chronic inflammation and its stratification by mutations in the Wnt signaling. |
Authors: |
Fujita, Masashi Matsubara, Nagahide Matsuda, Ikuo Maejima, Kazuhiro Oosawa, Ayako Yamano, Tomoki Fujimoto, Akihiro Furuta, Mayuko Nakano, Kaoru Oku-Sasaki, Aya Tanaka, Hiroko Shiraishi, Yuichi Mateos, Raúl Nicolás Nakai, Kenta Miyano, Satoru Tomita, Naohiro Hirota, Seiichi Ikeuchi, Hiroki Nakagawa, Hidewaki
|
Citation: |
Fujita M, etal., Oncotarget. 2017 Dec 12;9(1):969-981. doi: 10.18632/oncotarget.22867. eCollection 2018 Jan 2. |
RGD ID: |
151361225 |
Pubmed: |
PMID:29416670 (View Abstract at PubMed) |
PMCID: |
PMC5787528 (View Article at PubMed Central) |
DOI: |
DOI:10.18632/oncotarget.22867 (Journal Full-text) |
Inflammatory bowel disease (IBD) increases the risk of colorectal cancer, known as colitis-associated cancer (CAC). It is still unclear what driver mutations are caused by chronic inflammation and lead to CAC development. To get insight into this issue, we investigated somatic alterations in CAC. We performed exome sequencing of 22 fresh CACs and targeted sequencing of 43 genes on 90 archive specimens from Japanese CAC patients, of which 58 were ulcerative colitis (UC) and 32 were Crohn's disease (CD). Consistently with the previous reports, TP53 was commonly mutated (66%) whereas APC, KRAS and SMAD4 were mutated less frequently (16%, 11% and 11%, respectively). Mucinous CD-CACs in the anus, an Asian-specific subtype of CD-CAC, had less somatic mutations in our target genes. We also found that RNF43, a negative regulator of the Wnt signaling, was somatically mutated in a significant fraction of CACs (10 of 90; 11%). Two lines of evidence indicated that somatic mutations of RNF43 were related to chronic inflammation. First, somatic mutations of RNF43 were significantly associated with longer duration of IBD. Second, clinico-pathological features suggested many of the APC-mutated CACs were actually sporadic colorectal cancer whereas RNF43-mutated CACs did not have this tendency. RNA-Seq analysis showed that RNF43-mutated CACs had elevated expression of c-Myc and its target genes, suggesting that RNF43 is a bona fide driver of CAC development. This study provides evidence that somatic mutation of RNF43 is the driver genetic alteration that links chronic inflammation and cancer development in about 10% of CACs.
|
|